Literature DB >> 2900995

Astemizole-induced torsade de pointes.

F E Simons, M S Kesselman, N G Giddins, A N Pelech, K J Simons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2900995     DOI： 10.1016/s0140-6736(88)90656-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.

Authors:  Y G Yap; J Camm
Journal:  BMJ       Date:  2000-04-29

Review 2.  Intranasal corticosteroids for allergic rhinitis: superior relief?

Authors:  L P Nielsen; N Mygind; R Dahl
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.

Authors:  Deborah Layton; Vicki Osborne; Anna Gilchrist; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

5.  Torsades de pointes complicating treatment with terfenadine.

Authors:  T J MacConnell; A J Stanners
Journal:  BMJ       Date:  1991-06-15

Review 6.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

7.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

Review 8.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

Authors:  Geoffrey K Isbister; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

9.  Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonen; P Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.